A pragmatic patient-reported outcome strategy for rare disease clinical trials: application of the EORTC item library to myelodysplastic syndromes, chronic myelomonocytic leukemia, and acute myeloid leukemia.

MLA

Bell, Jill A., et al. “A Pragmatic Patient-Reported Outcome Strategy for Rare Disease Clinical Trials: Application of the EORTC Item Library to Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, and Acute Myeloid Leukemia.” Journal of Patient-Reported Outcomes, vol. 3, no. 1, June 2019, p. 35. EBSCOhost, https://doi.org/10.1186/s41687-019-0123-4.

APA

Bell, J. A., Galaznik, A., Pompilus, F., Strzok, S., Bejar, R., Scipione, F., Fram, R. J., Faller, D. V., Cano, S., & Marquis, P. (2019). A pragmatic patient-reported outcome strategy for rare disease clinical trials: application of the EORTC item library to myelodysplastic syndromes, chronic myelomonocytic leukemia, and acute myeloid leukemia. Journal of Patient-Reported Outcomes, 3(1), 35. https://doi.org/10.1186/s41687-019-0123-4

Chicago

Bell, Jill A, Aaron Galaznik, Farrah Pompilus, Sara Strzok, Rafael Bejar, Fatima Scipione, Robert J Fram, Douglas V Faller, Stefan Cano, and Patrick Marquis. 2019. “A Pragmatic Patient-Reported Outcome Strategy for Rare Disease Clinical Trials: Application of the EORTC Item Library to Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, and Acute Myeloid Leukemia.” Journal of Patient-Reported Outcomes 3 (1): 35. doi:10.1186/s41687-019-0123-4.